Aurinia Pharmaceuticals announced that two of their directors, Dr. George Milne and Mr. Joseph P. Hagan, have resigned following a lack of majority stockholder support at the annual meeting. The company has also begun exploring strategic alternatives including a potential sale, merger or other transaction.